4//SEC Filing
SHOVLIN ROBERT J. 4
Accession 0001077183-21-000134
CIK 0001077183other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:23 PM ET
Size
16.6 KB
Accession
0001077183-21-000134
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-25$8.03/sh+96,167$772,221→ 249,914 total - Exercise/Conversion
Common Stock
2021-05-25$19.60/sh+16,724$327,790→ 266,638 total - Exercise/Conversion
Common Stock
2021-05-25$28.33/sh+14,067$398,518→ 280,705 total - Sale
Common Stock
2021-05-25$39.31/sh−130,604$5,134,043→ 150,101 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−16,724→ 33,449 totalExercise: $19.60Exp: 2024-03-01→ Common Stock (16,724 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−14,067→ 42,204 totalExercise: $28.33Exp: 2027-03-02→ Common Stock (14,067 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-25−96,167→ 0 totalExercise: $8.03Exp: 2023-02-26→ Common Stock (96,167 underlying)
Holdings
- 38,688
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (38,688 underlying)
Footnotes (4)
- [F1]On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date
- [F2]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001621453
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 6:23 PM ET
- Size
- 16.6 KB